Targeted nanoparticles for simultaneous delivery of chemotherapeutic and hyperthermia agents - An in vitro study

Journal of Photochemistry and Photobiology B: Biology

Volumn 136, Issue , 2014, Pages 81-90

  Srinivasan, Supriya ^a   Manchanda, Romila ^a,b   Lei, Tingjun ^a,c   Nagesetti, Abhignyan ^a   Fernandez Fernandez, Alicia ^a,d   McGoron, Anthony J ^a  

^a The Department of Electrical and Computer Engineering   (United States)

^b GALGOTIAS UNIVERSITY   (India)

^c Cirle   (United States)

^d NOVA SOUTHEASTERN UNIVERSITY   (United States)

Author keywords

Doxorubicin; Drug delivery; Hyperthermia; Image guided therapy; Indocyanine green; Molecular imaging; Theranostics

Indexed keywords

ANTIBODY; ANTIINFECTIVE AGENT; DOXORUBICIN; HYPERTHERMIA AGENT; INDOCYANINE GREEN; MONOCLONAL ANTIBODY; NANOPARTICLE; POLYGLACTIN; SOLVENT; UNCLASSIFIED DRUG; ANTINEOPLASTIC ANTIBIOTIC; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ERBB2 PROTEIN, HUMAN; LACTIC ACID; POLYGLYCOLIC ACID; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER;

ARTICLE; CANCER CELL LINE; CONTROLLED STUDY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; EMULSION; HUMAN; HUMAN CELL; HYPERTHERMIA; IN VITRO STUDY; LOW LEVEL LASER THERAPY; PRIORITY JOURNAL; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; IMMUNOLOGY; TUMOR CELL LINE;

ANTIBIOTICS, ANTINEOPLASTIC; ANTIBODIES, MONOCLONAL; CELL LINE, TUMOR; CELL SURVIVAL; DOXORUBICIN; HUMANS; INDOCYANINE GREEN; LACTIC ACID; LASER THERAPY; NANOPARTICLES; POLYGLYCOLIC ACID; RECEPTOR, ERBB-2;

EID: 84901478163     PISSN: 10111344     EISSN: 18732682     Source Type: Journal    
DOI: 10.1016/j.jphotobiol.2014.04.012     Document Type: Article

References (54)

1. L. Liotta, and E. Petricoin Molecular profiling of human cancer Nat. Rev. Genet. 45 2000 48 56
2. B.K. Sinha, and E.G. Mimnaugh Free radicals and anticancer drug resistance: oxygen free radicals in the mechanisms of drug cytotoxicity and resistance by certain tumors Free Radical Biol. Med. 8 1990 567 581 (Pubitemid 20204420)
3. R. Cavaliere, E.C. Ciocatto, B.C. Giovanella, C. Heidelberger, R.O. Johnson, and M. Margottini Selective heat sensitivity of cancer cells: biochemical and clinical studies Cancer 20 1967 1351 1381
4. C. Christophi, A. Winkworth, V. Muralihdaran, and P. Evans The treatment of malignancy by hyperthermia Surg. Oncol. 7 1998 83 90 (Pubitemid 29273924)
5. V. Ntziachristos, C. Bremer, and R. Weissleder Fluorescence imaging with near-infrared light: new technological advances that enable in vivo molecular imaging Eur. Radiol. 13 2003 195 208 (Pubitemid 36790510)
6. R. Benya, J. Quintana, and B. Brundage Adverse reactions to indocyanine green: a case report and a review of the literature Catheter. Cardio. Diag. 17 1989 231 233 (Pubitemid 19188844)
7. W.R. Chen, R.L. Adams, A.K. Higgins, K.E. Bartels, and R.E. Nordquist Photothermal effects on murine mammary tumors using indocyanine green and an 808-nm diode laser: an in vivo efficacy study Cancer Lett. 98 1996 169 173 (Pubitemid 26010325)
8. M.D. Lucroy, W.R. Chen, T.D. Ridgway, R.G. Higbee, and K.E. Bartels Selective laser-induced hyperthermia for the treatment of spontaneous tumors in dogs JXST 10 2002 237 243 (Pubitemid 35427418)
9. V. Saxena, M. Sadoqi, and J. Shao Degradation kinetics of indocyanine green in aqueous solution J. Pharm. Sci. 92 2003 2090 2097 (Pubitemid 37175639)
10. A. Fernandez-Fernandez, R. Manchanda, and A.J. McGoron Theranostic applications of nanomaterials in cancer: drug delivery, image-guided therapy and multifunctional platforms Appl. Biochem. Biotechnol. 165 2011 1628 1651
11. L.S. Nair, and C.T. Laurencin Biodegradable polymers as biomaterials Prog. Polym. Sci. 32 2007 762 798 (Pubitemid 47198287)
12. F. Danhier, E. Ansorena, J.M. Silva, R. Coco, A.L. Breton, and V. Préat PLGA-based nanoparticles: an overview of biomedical applications J. Controlled Release 161 2012 505 522
13. Y. Maa, M. Sadoqib, and J. Shao Biodistribution of indocyanine green-loaded nanoparticles with surface modifications of PEG and folic acid Int. J. Pharm. 436 2012 25 31
14. J. Park, P.M. Fong, J. Lu, K.S. Russell, C.J. Booth, W.M. Saltzman, and T.M. Fahmy PEGylated PLGA nanoparticles for the improved delivery of doxorubicin Nanomed. Nanotech. Biol. Med. 5 2009 410 418
15. I. Brigger, C. Dubernet, and P. Couvreur Nanoparticles in cancer therapy and diagnosis Adv. Drug Deliver. Rev. 54 2002 631 651 (Pubitemid 35247520)
16. S.K. Hobbs, W.L. Monsky, F. Yuan, W.G. Roberts, L. Griffith, and V.P. Torchilin Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment Proc. Natl. Acad. Sci. USA 95 1998 4607 4612 (Pubitemid 28207960)
17. J. Vermeij, E. Teugels, C. Bourgain, J. Xiangming, P. Veld, V. Ghislain, B. Neyns, and J.D. Grève Genomic activation of the EGFR and HER2-neu genes in a significant proportion of invasive epithelial ovarian cancers BMC Cancer 8 2008 1 9
18. P. Nair Epidermal growth factor receptor family and its role in cancer progression Curr. Sci. 88 2005 890 898 (Pubitemid 40793573)
19. Y. Tang, T. Lei, R. Manchanda, A. Nagesetti, A. Fernandez-Fernandez, S. Srinivasan, and A.J. McGoron Simultaneous delivery of chemotherapeutic and thermal-optical agents to cancer cells by a polymeric (PLGA) nanocarrier: an in vitro study Pharm. Res. 27 2010 2242 2253
20. R. Manchanda, A. Fernandez-Fernandez, A. Nagesetti, and A.J. McGoron Preparation and characterization of a polymeric (PLGA) nanoparticulate drug delivery system with simultaneous incorporation of chemotherapeutic and thermo-optical agents Colloids Surf. B 75 2009 260 267
21. J. Yang, C. Lee, J. Park, S. Seo, E. Lim, Y.J. Song, J. Suh, H. Yoon, Y. Huh, and S. Haam Antibody conjugated magnetic PLGA nanoparticles for diagnosis and treatment of breast cancer J. Mater. Chem. 17 2007 2695 2699 (Pubitemid 47138959)
22. Y. Mo, and L.Y. Lim Preparation and in vitro anticancer activity of wheat germ agglutinin (WGA)-conjugated PLGA nanoparticles loaded with paclitaxel and isopropyl myristate J. Controlled Release 107 2005 30 42 (Pubitemid 41253700)
23. A. Monks, D. Scudiero, P. Skehan, R. Shoemaker, K. Paull, and D. Vistica Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor-cell lines J. Natl. Cancer Inst. 83 1991 757 766
24. Y. Tang, and A.J. McGoron Combined effects of laser-ICG photothermotherapy and doxorubicin chemotherapy on ovarian cancer cells J. Photochem. Photobiol. B 97 2009 138 144
25. T. Lei, S. Srinivasan, Y. Tang, R. Manchanda, A. Nagesetti, A. Fernandez-Fernandez, and A.J. McGoron Comparing cellular uptake and cytotoxicity of targeted drug carriers in cancer cell lines with different drug resistance mechanisms Nanomed. Nanotech. Biol. Med. 7 2010 324 332
26. B. Haley, and E. Frenkel Nanoparticles for drug delivery in cancer treatment Urol. Oncol. 26 2008 57 64
27. D.B. Kirpotin, D.C. Drummond, Y. Shao, M.R. Shalaby, K. Hong, U.B. Nielsen, J.D. Marks, C.C. Benz, and J.W. Park Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models Cancer Res. 66 2006 6732 6740 (Pubitemid 44085631)
28. S. Barua, J. Yoo, P. Kolhar, A. Wakankar, Y.R. Gokarn, and S. Mitragotri Particle shape enhances specificity of antibody-displaying nanoparticles PNAS 110 2013 3270 3275
29. C. Chittasupho, S.X. Xie, A. Baoum, T. Yakovleva, T.J. Siahaan, and C.J. Berkland ICAM-1 targeting of doxorubicin-loaded PLGA nanoparticles to lung epithelial cells Eur. J. Pharm. Sci. 37 2009 141 150
30. M. Zheng, C. Yue, Y. Ma, P. Gong, P. Zhao, C. Zheng, Z. Sheng, P. Zhang, Z. Wang, and L. Cai Single-step assembly of DOX/ICG loaded lipid polymer nanoparticles for highly effective chemo-photothermal combination therapy ACS Nano 7 2013 2056 2067
31. T. Lei, R. Manchanda, A. Fernandez-Fernandez, Y.C. Huang, D. Wright, and A.J. McGoron Thermal and pH sensitive multifunctional polymer nanoparticles for cancer imaging and therapy RSC Adv. 4 2014 17959 17968
32. R. Dinarvand, N. Sepheri, S. Manoochehri, H. Rouhani, and F. Atyabi Polylactide-co-glycolide nanoparticles for controlled delivery of anticancer agents Int. J. Nanomed. 6 2011 877 895
33. P. Kocbek, N. Obermajer, M. Cegnar, J. Kos, and J. Kristl Targeting cancer cells using PLGA nanoparticles surface modified with monoclonal antibody J. Controlled Release 120 2007 18 26 (Pubitemid 46874614)
34. F. Xu, Y. Yu, X.F. Le, C. Boyer, G.B. Mills, and R.C. Bast The outcome of heregulin-induced activation of ovarian cancer cells depends on the relative levels of HER-2 and HER-3 expression Clin. Cancer Res. 5 1999 3653 3660
35. J. Kurebayashi Biological and clinical significance of HER2 overexpression in breast cancer Breast Cancer 8 2001 45 51
36. S. Rudnick, J. Lou, C.C. Shaller, Y. Tang, A.J.P. Klein-Szanto, L.M. Weiner, J.D. Marks, and G.P. Adams Influence of affinity and antigen internalization on the uptake and penetration of anti-HER2 antibodies in solid tumors Cancer Res. 71 2011 2250 2259
37. F. Tewes, E. Munnier, B. Antoon, L. Ngaboni-Okassa, S. Cohen-Jonathan, and H. Marchais Comparative study of doxorubicin-loaded poly(lactide-co- glycolide) nanoparticles prepared by single and double emulsion methods Eur. J. Pharm. Biopharm. 66 2007 488 492 (Pubitemid 46756231)
38. O. Harush-Frenkel, N. Debotton, S. Benita, and Y. Altschuler Targeting of nanoparticles to the clathrin-mediated endocytic pathway Biochem. Biophys. Res. Co. 353 2007 26 32 (Pubitemid 44958337)
39. M. Ogris, P. Steinlein, S. Carotta, S. Brunner, and E. Wagner DNA/polyethylenimine transfection particles: influence of ligands, polymer size, and PEGylation on internalization and gene expression AAPS Pharm. Sci. 3 2001 43 53
40. J.K. Vasir, and V. Labhasetwar Targeted drug delivery in cancer therapy Technol. Cancer Res. Treat. 4 2005 363 374 (Pubitemid 41242611)
41. C.W. Liu, and W.J. Lin Polymeric nanoparticles conjugate a novel heptapeptide as an epidermal growth factor receptor-active targeting ligand for doxorubicin Int. J. Nanomed. 7 2012 4749 4767
42. K.E. Coldwell, S.M. Cutts, T.J. Ognibene, P.T. Henderson, and D.R. Phillips Detection of adriamycin-DNA adducts by accelerator mass spectrometry at clinically relevant adriamycin concentrations Nucleic Acids Res. 36 e100 2008 101 110
43. Y. Tang, and A.J. McGoron Increasing the rate of heating: a potential therapeutic approach for achieving synergistic tumour killing in combined hyperthermia and chemotherapy Int. J. Hyperther. 29 2013 145 155
44. A.K. Sood, M.S. Fletcher, J.E. Coffin, M. Yang, E.A. Seftor, L.M. Gruman, D.M. Gershenson, and M.J.C. Hendrix Functional role of matrix metalloproteinases in ovarian tumor cell plasticity Am. J. Obstet. Gynecol. 190 2004 899 909 (Pubitemid 38561505)
45. B.B. Wolf, M. Schuler, W. Li, B. Eggers-Sedlet, W. Lee, P. Tailor, P. Fitzgerald, G.B. Mills, and D.R. Green Defective cytochrome c-dependent caspase activation in ovarian cancer cell lines due to diminished or absent apoptotic protease activating factor-1 activity J. Biol. Chem. 276 2001 34244 34251
46. B. Van de Broek, N. Devoogdt, A. D'Hollander, H.L. Gijs, K. Jans, L. Lagae, S. Muyldermans, G. Maes, and G. Borghs Specific cell targeting with nanobody conjugated branched gold nanoparticles for photothermal therapy ACS Nano 5 2011 4319 4328
47. R. Manchanda, A. Fernandez-Fernandez, D. Carvajal, T. Lei, Y. Tang, and A.J. McGoron Nanoplexes for cell imaging and hyperthermia: in vitro studies J. Biomed. Nanotechnol 8 2012 686 694
48. A. Fernandez-Fernandez, R. Manchanda, T. Lei, D.A. Carvajal, Y. Tang, S.Z. Kazmi, and A.J. McGoron Comparative study of the optical and heat generation properties of IR820 and indocyanine green Mol. Imag. 11 2012 99 113
49. S. Srinivasan, R. Manchanda, A. Fernandez-Fernandez, T. Lei, and A.J. McGoron Near-infrared fluorescing IR820-chitosan conjugate for multifunctional cancer theranostic applications J. Photochem. Photobiol. B 119 2013 52 59
50. D.W. Loe, R.O. Deeley, and S.P.C. Cole Biology of the multidrug resistance associated protein, MRP Eur. J. Cancer 32A 1996 945 957
51. Z. Yang, E.L. Woodahl, X.Y. Wang, T. Bui, D.D. Shen, and R.J.Y. Ho Semi-quantitative RT-PCR method to estimate full-length mRNA levels of the multidrug resistance gene Biotechniques 33 2002 196 203 (Pubitemid 34791138)
52. H.H. Kampinga Cell biological effects of hyperthermia alone or combined with radiation or drugs: a short introduction to newcomers in the field Int. J. Hyperther. 22 2006 191 196 (Pubitemid 43878678)
53. J.R. Lepock Cellular effects of hyperthermia: relevance to the minimum dose for thermal damage Int. J. Hyperther. 19 2003 252 266 (Pubitemid 36740798)
54. K. Franke, M. Kettering, K. Lange, W.A. Kaiser, and I. Hilger The exposure of cancer cells to hyperthermia, iron oxide nanoparticles, and mitomycin C influences membrane multidrug resistance protein expression levels Int. J. Nanomed. 8 2013 351 363